83 related articles for article (PubMed ID: 7030162)
1. Improved survival of pancreas transplants.
Toledo-Pereyra LH; Zammit M; Gordon DA; MacKenzie GH
Am Surg; 1981 Oct; 47(10):452-8. PubMed ID: 7030162
[No Abstract] [Full Text] [Related]
2. Minnesota experience with 81 pancreas transplants since 1978.
Sutherland DE; Chinn PL; Goetz FC; Elick BA; Najarian JS
Transplant Proc; 1984 Jun; 16(3):695-703. PubMed ID: 6375036
[No Abstract] [Full Text] [Related]
3. Incidence and impact of acute rejection episodes on short- and long-term graft survival in recipients of simultaneous pancreas-kidney transplantation.
Cantarovich D; Giral M; Josien R; Karam G; Hourmant M; Dantal J; Blancho G; Soulillou JP
Transplant Proc; 1995 Feb; 27(1):1319. PubMed ID: 7878897
[No Abstract] [Full Text] [Related]
4. Is induction therapy necessary for successful simultaneous pancreas and kidney transplantation in the cyclosporine era?
Brayman KL; Egidi MF; Naji A; Friedman AL; Holland MT; Tomaszewski JE; Samini F; Perloff J; Grossman R; Barker CF
Transplant Proc; 1994 Oct; 26(5):2525-7. PubMed ID: 7940776
[No Abstract] [Full Text] [Related]
5. Outcome of monoclonal antibody induction and anti-rejection therapy in pancreas transplantation.
Bruce DS; Newell KA; Woodle ES; Millis JM; Piper JB; Huss E; Thistlethwaite JR
Transplant Proc; 1996 Aug; 28(4):2136-7. PubMed ID: 8769180
[No Abstract] [Full Text] [Related]
6. Effect of immunosuppression on pancreatic graft survival and function.
La Rocca E; Dubernard JM; Camozzi L; LeFrancois N; Faure JL; Sanseverino R; Melandri M; Finaz J; Martin X; Gelet A
Transplant Proc; 1987 Oct; 19(5):3950-2. PubMed ID: 3313972
[No Abstract] [Full Text] [Related]
7. FK 506-based immunosuppression in clinical pancreas transplantation.
Swanson C; Rubin M; Colquhoun S; Basadonna G; Asshinnik A; Perez R
Transplant Proc; 1995 Dec; 27(6):3031. PubMed ID: 8539827
[No Abstract] [Full Text] [Related]
8. Renal transplantation at the University of Wisconsin in the cyclosporine era.
Knechtle SJ; Pirsch JD; D'Alessandro AM; Sollinger HW; Kalayoglu M; Belzer FO
Clin Transpl; 1993; ():211-8. PubMed ID: 7918154
[TBL] [Abstract][Full Text] [Related]
9. The efficiency of sheep antidog antilymphocyte serum (SADALS) in the prolongation of canine heart allografts.
Halpern B; Cachera JP; Lacombe M; Hathaway A; Crepin Y; Hung BM; Lacassagne JP; Leandri J; Laurent D; Dubost C; de Mendoza M
Transplant Proc; 1969 Mar; 1(1):467-9. PubMed ID: 4944261
[No Abstract] [Full Text] [Related]
10. Adjuncts to triple-drug therapy after cardiac transplantation: a comparison of Nashville rabbit antithymocyte serum to OKT3.
Aziz S; Kruse AP; Roby PV; Allen MD; Khan K; Fishbein D
Transplant Proc; 1994 Oct; 26(5):2721-3. PubMed ID: 7940852
[No Abstract] [Full Text] [Related]
11. 20-year follow-up results of a randomized controlled trial comparing antilymphocyte globulin induction to no induction in renal transplant patients.
Cantarovich M; Durrbach A; Hiesse C; Ladouceur M; Benoit G; Charpentier B
Transplantation; 2008 Dec; 86(12):1732-7. PubMed ID: 19104413
[TBL] [Abstract][Full Text] [Related]
12. Cyclosporin monotherapy in pancreaticorenal transplantation.
Ward RG; Gecim E; Bone JM; Bakran A; Sells RA
Transplant Proc; 1994 Apr; 26(2):548. PubMed ID: 8171547
[No Abstract] [Full Text] [Related]
13. Neoquadruple induction with antithymocyte globulin/azathioprine/cyclosporine/prednisolone in simultaneous pancreas and kidney transplant recipients: 8.5-year results.
Schulz T; Kapischke M; Busing M
Transplant Proc; 2005 May; 37(4):1815-7. PubMed ID: 15919475
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous homotransplantation of heart and kidney from the same donor in bilaterally nephrectomized dogs.
Legrain M; Gandjbakhch ; Dubois M; Wajcner G; Rottembourg J; Guilmet D
Transplant Proc; 1969 Mar; 1(1):293-5. PubMed ID: 4944230
[No Abstract] [Full Text] [Related]
15. Pancreas transplant outcomes for United States (US) cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR).
Gruessner AC; Sutherland DE
Clin Transpl; 2008; ():45-56. PubMed ID: 19708445
[TBL] [Abstract][Full Text] [Related]
16. [Kidney-pancreas transplantation. Clinical results in 23 consecutive patients].
Maestri M; Krieger N; Kuo P; Dafoe DC; Alfrey EJ
Minerva Chir; 1998 Mar; 53(3):121-8. PubMed ID: 9617106
[TBL] [Abstract][Full Text] [Related]
17. Effects of three immunosuppressive drug protocols on cadaver renal transplantation costs after 4 years of therapy.
Canafax DM; Carleton BC; Matas AJ; Payne WD; Dunn DL; Sutherland DE; Najarian JS
Transplant Proc; 1993 Feb; 25(1 Pt 2):1692-3. PubMed ID: 8442239
[No Abstract] [Full Text] [Related]
18. Successful pancreas-renal transplantation without anti-T-cell antibody induction.
Shapiro ME; Abrams JM; Brown RS; Steinman TI; Strom TB
Transplant Proc; 1995 Dec; 27(6):3087-8. PubMed ID: 8539857
[No Abstract] [Full Text] [Related]
19. Combined pancreas-kidney transplants using quadruple immunosuppression therapy: a comparison between antilymphoblast and antithymocyte globulins.
Fasola CG; Hricik DE; Schulak JA
Transplant Proc; 1995 Dec; 27(6):3135-6. PubMed ID: 8539880
[No Abstract] [Full Text] [Related]
20. OKT3 first-line treatment of acute rejection episodes following combined pancreas and kidney transplantation.
Cantarovich D; Hourmant M; Dantal J; Giral M; Paineau J; Karam G; Soulillou JP
Transplant Proc; 1994 Apr; 26(2):549. PubMed ID: 8171548
[No Abstract] [Full Text] [Related]
[Next] [New Search]
